Found 7 matching trials
Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients
PHASE2Patients with cystic fibrosis (CF) suffer from chronic infections of the lo...
Location
Multiple Locations
MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis
PHASE3Patients with cystic fibrosis (CF) suffer from chronic infections of the lo...
Location
Multiple Locations
Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
PHASE1Patients with cystic fibrosis (CF) suffer from chronic infections of the lo...
Location
Multiple Locations
A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients
PHASE2Patients with Chronic Obstructive Pulmonary Disease (COPD) suffer from freq...
Location
Multiple Locations
"Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"
PHASE1Patients with cystic fibrosis (CF) suffer from chronic infections of the lo...
Location
Multiple Locations
Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients
PHASE3Patients with cystic fibrosis (CF) suffer from chronic infections of the lo...
Location
Multiple Locations
A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients
PHASE1Patients with Chronic Obstructive Pulmonary Disease (COPD) suffer from freq...
Location
Multiple Locations